Scienture Holdings, Inc. (SCNX): Operating Cash Flow
-$13.38M
Year ended 2025-12-31
-$14.44M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$13.38M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$14.27M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$2.23M | n/m | 2025-03-26, From 2023-01-01 |
| 2022-12-31 | -$1.53M | n/m | 2023-03-27, From 2022-01-01 |
| 2021-12-31 | -$2.57M | n/m | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | -$2.21M | n/m | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | $141.8K | -48.1% | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | $273.4K | +59.3% | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $171.7K | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | -$503.5K | n/m | 2017-03-30, From 2016-01-01 |
| 2015-12-31 | $90.4K | n/m | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | -$1.06M | n/m | 2016-03-28, From 2014-01-01 |
| 2013-12-31 | -$844.6K | n/a | 2015-03-23, From 2013-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | -$13.38M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$9.81M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$8.95M | n/m |
| America Great Health (AAGH) | 2025-06-30 | -$332.9K | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | -$30.97M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$3.95M | n/m |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | -$10.98M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$3.33M | n/m |
| Silence Therapeutics plc (SLN) | 2025-12-31 | -$62.27M | n/m |
Compare SCNX, MNOV, CANF, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗